Zogenix has bounced back from the FDA’s rejection of its only drug, with the acquisition of Modis Therapeutics and a developmental rare disease drug that has already been championed by regulators in ...
Nonprofit organizations, and organizations hosting events benefiting nonprofits, are eligible for publicity via the KSBW.com Community Calendar. Please email all necessary information, including the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results